From April 2005 until October 2009 , 60 patients ( 32 men ) with a median age of 42 ( 25-82 ) years were randomized to receive either ISDN 10 mg/ml ( 1 % ) ( n = 33 ) or injection with 60 units of Dysport ( n = 27 ) .